References
- Baker JG, Hill SJ, Summers RJ. Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling. Trends Pharmacol Sci. 2011;32:227-234.
- Ballesteros JA, Weinstein H. Integrated methods for the construction of threedimensional models and computational probing of structure-function relationship in Gprotein coupled receptors. Methods Neurosci. 1995;23:366-428
- Borchard U. Pharmacological properties of β-adrenoceptor blocking drugs. J Clin Bas Cadiol. 1998;1:5-9.
- Čižmarikova R, Račanska E, Hroboňova K, Lehotay J, Aghova Y, Halešova D. Synthesis and pharmacological activity and chromatographic separation of novel potential β-blockers of the aryloxyaminopropanol type. Pharmazie. 2003;58:237-241.
- Heilker R, Wolff M, Tautermann ChS, Bieler M. G-protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discov Today. 2009;14:231-240.
- Hieble JP. Adrenoceptors subclassification: an approach to improved cardiovascular therapeutics. Pharmacochem Lib. 2000;31:163-171.
- Horn F, Weare J, Beukers MW, et al. GPCRDB: an information system for G proteincoupled receptors. Nucleic Acids Res. 1998;26:275-279.
- Jaakola VP, IjzermanAP. The crystallographic structure of the adenosine A2A receptor in high-affinity antagonist-bound state: implication for GPCR drug screening and design. Curr Opinion Struct Biol. 2010;20:401-414.
- Jacobson KA, Constanzi S. New insights for drug design from the X-ray crystallographic structure of G-protein-coupled receptors. Mol Pharmacol. 2012;82:361-371.
- Johannes A, Kellershohn K, Mohr-Adra M, et al. Dualsteric GPCR targeting: a novel route to binding and signaling pathway selectivity. FASEB. 2009;23:442-450.
- Okada T, Le Trong I, Fox BA, Behnke CA, Stenkamp RE, Palczewski K. X-ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. J Struct Biol. 2000;130:73-80.
- Peeters MC, van Westen GJP, Li Q, IJzerman AP. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and activation. Trends Pharmacol Sci. 2011;32:35-42.
- Rasmussen S, Choi H, Rosenbaum D, et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature. 2007;450:383-387.
- Shoichet BK, McGovern SL, Wei B, Itwin J. Lead discovery using molecular docking. Curr Opinion Chem Biol. 2002;6:439-446.
- Sybyl. Molecular Modeling Software Package, Tripos mc., St. Louis MO 63144 USA, 2011.
- Topiol S, Sabio M. X-ray structure breakthroughs in the GPCR transmembrane region. Biochem Pharmacol. 2009;78:11-20.
- Warne T, Serrano-Vega M, Baker J, et al. Structure of a β1 adrenergic G-proteincoupled receptor. Nature. 2008;454:486-491.
- Warne T, Moukhametzianov R, Baker JG, et al. The structural basis for agonist and partial agonist action on a β1-adrenergic receptor. Nature. 2011;469:241-244.
- Warne T, Edwards PC, Leslie AGW, Tate C. Crystal structures of stabilized β1- adrenoceptor bound to the biased agonists bucindolol and carvedilol. Structure. 2012;20:841-849.